TherapeuticsMD Inc (TXMD) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $2.19 (+0.46%), Market cap $0.02B, 52-week low–high $1.04 ~ $2.77.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc.
Financial statements, price targets, institutional (13F) holdings and related news for TherapeuticsMD Inc are updated in real time on BlackAll Trade.
TherapeuticsMD Inc trades at $2.19 (+0.46%). Real-time quotes and charts are available on BlackAll Trade.
TherapeuticsMD Inc has a market cap of about $0.02B.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia,